Hjarta Care has developed the XgraftR, a patented device for the non-invasive extraction of aortic stent grafts, ensuring safe and efficient removal. This technology addresses the risks associated with traditional stent graft removal procedures, enhancing patient safety and recovery times.
Funding
$850K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional aortic stent graft removal is a complex surgical procedure associated with significant risks, including damage to the aorta and surrounding tissues, prolonged recovery times, and potential complications. Current methods often involve invasive techniques that can lead to patient morbidity and mortality.
Solution
Hjarta Care has engineered the XgraftR, a patented device designed for the safe and non-invasive extraction of aortic stent grafts. This technology mitigates the risks associated with conventional stent graft removal by providing a controlled and precise method for explantation. The XgraftR aims to improve patient outcomes by reducing the potential for aortic damage, minimizing recovery periods, and enhancing the overall efficiency of the removal process. The device is the result of over 20 years of clinical observation.
Target Audience
The primary target audience includes vascular surgeons and interventional radiologists specializing in aortic procedures, as well as hospitals and medical centers performing stent graft explantations.
Features
- Patented device specifically designed for aortic stent graft extraction.
- Non-invasive approach minimizes trauma to the aorta and surrounding tissues.
- Controlled extraction process ensures precise and safe removal of the stent graft.
- Aims to reduce patient recovery times compared to traditional surgical methods.